M-1218 — MED Retatrutide
Vendor COAMED | Retatrutide, last activity 1 month ago
5 related batch concerns
Get notified when a lab result is posted, a group test forms, or this batch is flagged by the community.
Test Results
The label says 20 mg. Janoshik weighed 21.3 mg — 6% more than the label. Your dose depends on what is really in the vial, so the steps below use the measured amount.
Draw
19 units
on a U-100 insulin syringe, for 2 mg
Going by the label you would draw 20 units — which from this vial is actually 2.13 mg, not 2 mg.
- The vial holds dry powder: 21.3 mg of Retatrutide, as weighed.
- Water spreads that powder evenly through the liquid: 21.3 mg ÷ 2 ml = 10.6 mg per ml.
- An insulin syringe counts in units, 100 to the ml, so each unit carries 106 mcg.
- Your dose divided by that: 2 mg ÷ 106 mcg = 19 units.
The water changes how many units a dose takes, never how much peptide you get. Twice the water means twice the units for the same dose. What sets the dose is how much is in the vial — which is why the measured amount matters.
Arithmetic, not medical advice. Assumes a U-100 syringe and that the powder fully dissolves. The figure is from the vial that was tested; yours is from the same lot but was not weighed itself.
Related batches
5 of 5 tested
same lot series
same lot series
also MED
1 community mention, no summary yet
Tirzepatide, same vendor
1 community mention, no summary yet
APS
An independent test found endotoxin at 1,437.86 EU/vial, far exceeding the 10 EU/vial working limit, while the vendor's…
Community Intelligence
- 1 concern report involving REPTN
- 2 concern reports involving 2026041210
- 4 concern reports involving XTP-R30-003
- 1 concern report involving JP20250821
- 1 concern report involving REPTN-1
Reported against other MED Retatrutide batches, not this one.
Also known as: M1218
Activity
No community activity tracked yet.
Vendor
MED